Joyce Williams

Joyce Williams has extensive work experience in finance and accounting. Joyce most recently worked at Cerevel Therapeutics as the Vice President, Corporate Controller since July 2022. Prior to that, they held the position of Sr. Director, Corporate Controller at Cerevel Therapeutics from October 2019 to July 2022. Before joining Cerevel Therapeutics, they served as the Vice President, Corporate Controller at KSQ Therapeutics, Inc. from February 2019 to October 2019. Joyce also had experience as an Assistant Controller at Bioverativ, a Sanofi company from February 2017 to January 2019. Earlier in their career, they worked at Biogen as Sr. Manager, Accounting - Director, Finance from June 2007 to February 2017. Joyce also worked at Red Bull North America as the Director of Finance & Administration from September 2000 to May 2007. Joyce started their career at Ernst & Young as an Assurance Senior from September 1996 to October 1999.

Joyce Williams earned their Bachelor of Science (BS) degree in Accounting from Saint Joseph's University - Erivan K. Haub School of Business, attending from 1992 to 1996. Following their undergraduate education, they pursued a Master of Business Administration (MBA) degree in Business at Pepperdine Graziadio Business School, studying from 2002 to 2005.